Quotes NGM Biopharmaceuticals, Inc.

Equities

NGM

US62921N1054

Biotechnology & Medical Research

Delayed Nasdaq 04:00:00 2024-04-04 pm EDT 5-day change 1st Jan Change
1.54 USD -1.28% Intraday chart for NGM Biopharmaceuticals, Inc. -.--% +79.28%

Performance

1 day-1.28%
3 months+0.98%
6 months+101.60%
Current year+79.28%
1 year-51.42%
3 years-90.38%
5 years-89.70%

Volumes

markets
Daily volume
2 390 830
Estimated daily volume
2 390 830
Record volume 1
23 660 837
Record volume 2
11 736 720
Record volume 3
7 820 374
Capital turnover ratio
0.00
Float rotation
0.00

Basic data

Capitalization (USD)
128 532 108
Net sales ()
4
Number of employees
138
Sales / Employee ()
0
Sales / Employee (USD)
0
Free-Float
98.11 %
Free-Float capitalization (USD)
126 104 936

Highs and lows

Current year
1.01
Extreme 1.01
2.20
1 year
0.60
Extreme 0.6002
3.75
3 years
0.60
Extreme 0.6002
27.25
5 years
0.60
Extreme 0.6002
32.12
10 years
0.60
Extreme 0.6002
32.12

Indicators

Moving average 5 days
1.56
Moving average 100 days
1.24
Price spread / (MMA5)
+0.97%
Price spread / (MMA100)
-19.33%
RSI 9 days
0.00
RSI 14 days
0.00

Sector Comparison - Bio Therapeutic Drugs

Name Change 5d. change 1st Jan change 1-year change Capi.
-1.28%-.--%+79.28%-51.42% 129M
+1.36%+2.64%+12.30%+38.47% 118B
+0.45%+0.28%+12.15%+35.86% 106B
-2.07%+7.00%-8.14%-7.90% 23.4B
+0.66%-0.65%-1.69%-9.73% 21.78B
-4.86%-5.61%-10.60%-31.68% 18.09B
-1.25%-4.79%-41.25%-35.25% 16.72B
-2.22%-11.65%-15.33%-35.54% 15.97B
-0.79%-2.03%+5.80%+52.82% 14.03B
-2.89%-6.03%+28.03%-2.65% 11.67B
+4.84%-8.30%-31.18%-34.41% 7.55B
-0.72%-1.83%-2.52%+23.74% 7.53B
-0.74%-7.79%+9.49%+40.41% 7.48B
+0.75%+7.67%+3.54%+45.30% 7.48B
+1.92%-6.34%+237.18%+194.46% 6.92B
-3.70%-14.25%-59.32%-71.33% 6.62B
Average-0.63%-3.03%+13.61%+9.45%
Weighted average by Cap.+0.02%-0.43%+7.44%+21.45%

Historical data

DateOpeningHighLowEnd-of-dayVolume
Chart NGM Biopharmaceuticals, Inc.
More charts

Monthly variations

Annual change

2024+79.28%
2023-82.89%
2022-71.65%
2021-41.54%
2020+63.85%
2019+25.78%
  1. Stock Market
  2. Equities
  3. NGM Stock
  4. Quotes NGM Biopharmaceuticals, Inc.